| Title |
Evaluation of visible light and natural photosensitizers against Staphylococcus epidermidis and Staphylococcus saprophyticus planktonic cells and biofilm / |
| Authors |
Gricajeva, Alisa ; Buchovec, Irina ; Kalėdienė, Lilija ; Badokas, Kazimieras ; Vitta, Pranciškus |
| DOI |
10.1016/j.heliyon.2024.e28811 |
| Full Text |
|
| Is Part of |
Heliyon.. Elsevier Ltd. 2024, vol. 10, iss. 7, art. no. e28811, p. [1-15].. ISSN 2405-8440 |
| Keywords [eng] |
antimicrobial photoinactivation ; bacterial biofilms ; chlorophyllin ; riboflavin ; staphylococci ; superoxide anion detection |
| Abstract [eng] |
Antimicrobial photoinactivation (API) has shown some promise in potentially treating different nosocomial bacterial infections, however, its application on staphylococci, especially other than Staphylococcus aureus or methicillin-resistant S. aureus (MRSA) species is still limited. Although S. aureus is a well-known and important nosocomial pathogen, several other species of the genus, particularly coagulase-negative Staphylococcus (CNS) species such as Staphylococcus epidermidis and Staphylococcus saprophyticus, can also cause healthcare-associated infections and foodborne intoxications. CNS are often involved in resilient biofilm formation on medical devices and can cause infections in patients with compromised immune systems or those undergoing invasive procedures. In this study, the effects of chlorophyllin and riboflavin-mediated API on S. epidermidis and S. saprophyticus planktonic cells and biofilm are demonstrated for the first time. Based on the residual growth determination and metabolic reduction ability changes, higher inactivating efficiency of chlorophyllin-mediated API was determined against the planktonic cells of both tested species of bacteria and against S. saprophyticus biofilm. Some insights on whether aqueous solutions of riboflavin and chlorophyllin, when illuminated with optimal exciting wavelength (440 nm and 402 nm, respectively) generate O2−•, are also provided in this work. |
| Published |
Elsevier Ltd |
| Type |
Journal article |
| Language |
English |
| Publication date |
2024 |
| CC license |
|
